Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
For many, that means gaining weight back or losing the health benefits they had while on the medicine
A prescription and clinical evaluation are required
In a nationally representative sample of US adults, eligibility moved from 51.5% to 51.8%
The SURMOUNT series evaluated tirzepatide against placebo and semaglutide
Patients should never administer two doses to 'catch up', as this increases the risk of adverse effects, particularly gastrointestinal symptoms
US$ 27.07
US$ 27.53
US$ 23.23
US$ 27.82
